This is an open-label, multi-center, Phase 1/2 clinical trial evaluating the safety and effectiveness of EB103 in R/R B-cell NHL patients with the highest unme…

B-Cell Non-Hodgkin's Lymphoma (NHL)Lymphoma, Non-HodgkinsLymphomas Non-Hodgkin's B-Cell+12 more

~Estimated

~$10 – $8,750

Estrella Immunopharma, Inc.NCT06343311

Phase 2

A Phase 2 Study of Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a Complete Response With Upfront Chemoimmunotherapy

This research is being done to see if epcoritamab is effective in treating follicular lymphoma as a second line of treatment. The name of the study drug in th…

LymphomaFollicular LymphomaLymphoma,Non-Hodgkin+1 more

~Estimated

~$10 – $6,250

Beth Israel Deaconess Medical CenterNCT06510361